HRT FINANCIAL LP

Holdings History for Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

Symbol: PRLD on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0%	$0	0	-16,901	-100%	$2.15	Q4 2025
30 Sep 2025	0%	+0%	$24,000	16,901	+16,901	NEW	$1.42	Q3 2025
30 Jun 2023		-0%	$0	0	-22,175	-100%	$2.15	Q2 2023
31 Mar 2023	0%	+0%	$126,000	22,175	+22,175	NEW	$5.68	Q1 2023
31 Mar 2022		-0.01%	$0	0	-114,249	-100%	$2.15	Q1 2022
31 Dec 2021	0.01%	+0.01%	$1,422,000	114,249	+98,690	+634%	$12.45	Q4 2021
30 Sep 2021	0%	+0%	$486,000	15,559	+15,559	NEW	$31.24	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.